State of New Jersey Common Pension Fund D’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $693K | Buy |
9,933
+1,645
| +20% | +$120K | ﹤0.01% | 1597 |
|
|
2026
Q1 | $596K | Buy |
+8,288
| New | +$472K | ﹤0.01% | 1441 |
|
|
2022
Q4 | – | Sell |
-34,394
| Closed | -$1.65M | – | 1724 |
|
|
2022
Q3 | $1.65M | Sell |
34,394
-4,639
| -12% | -$276K | 0.01% | 1607 |
|
|
2022
Q2 | $2.23M | Buy |
39,033
+23,165
| +146% | +$1.46M | 0.01% | 1258 |
|
|
2022
Q1 | $1.28M | Hold |
15,868
| – | – | ﹤0.01% | 1651 |
|
|
2021
Q4 | $3.22M | Buy |
15,868
+2,439
| +18% | +$529K | 0.01% | 985 |
|
|
2021
Q3 | $3.62M | Buy |
13,429
+4,286
| +47% | +$1.03M | 0.01% | 904 |
|
|
2021
Q2 | $2.35M | Buy |
9,143
+1,381
| +18% | +$382K | 0.01% | 1561 |
|
|
2021
Q1 | $2.33M | Sell |
7,762
-690
| -8% | -$215K | 0.01% | 1443 |
|
|
2020
Q4 | $2.15M | Buy |
8,452
+79
| +0.9% | +$20.4K | 0.01% | 1471 |
|
|
2020
Q3 | $2.08M | Buy |
8,373
+312
| +4% | +$98.1K | 0.01% | 1316 |
|
|
2020
Q2 | $2.8M | Sell |
8,061
-424
| -5% | -$132K | 0.01% | 924 |
|
|
2020
Q1 | $2.27M | Hold |
8,485
| – | – | 0.01% | 933 |
|
|
2019
Q4 | $2.75M | Sell |
8,485
-402
| -5% | -$117K | 0.01% | 1090 |
|
|
2019
Q3 | $2.43M | Sell |
8,887
-27,113
| -75% | -$9.94M | 0.01% | 1207 |
|
|
2019
Q2 | $19.2M | Hold |
36,000
| – | – | 0.07% | 294 |
|
|
2019
Q1 | $18.1M | Buy |
36,000
+1,000
| +3% | +$593K | 0.07% | 302 |
|
|
2018
Q4 | $17.3M | Buy |
35,000
+28,000
| +400% | +$16.9M | 0.07% | 284 |
|
|
2018
Q3 | $6.4M | Hold |
7,000
| – | – | 0.02% | 537 |
|
|
2018
Q2 | $5.13M | Hold |
7,000
| – | – | 0.02% | 588 |
|
|
2018
Q1 | $11.2M | Hold |
7,000
| – | – | 0.04% | 394 |
|
|
2017
Q4 | $6.27M | Hold |
7,000
| – | – | 0.02% | 528 |
|
|
2017
Q3 | $2.52M | Hold |
7,000
| – | – | 0.01% | 709 |
|
|
2017
Q2 | $2.05M | Hold |
7,000
| – | – | 0.01% | 729 |
|
|
2017
Q1 | $2.46M | Hold |
7,000
| – | – | 0.01% | 692 |
|
|
2016
Q4 | $1.29M | Hold |
7,000
| – | – | 0.01% | 799 |
|
|
2016
Q3 | $1.8M | Hold |
7,000
| – | – | 0.01% | 743 |
|
|
2016
Q2 | $1.49M | Hold |
7,000
| – | – | 0.01% | 757 |
|
|
2016
Q1 | $1.44M | Hold |
7,000
| – | – | 0.01% | 759 |
|
|
2015
Q4 | $1.77M | Hold |
7,000
| – | – | 0.01% | 756 |
|
|
2015
Q3 | $1.15M | Hold |
7,000
| – | – | ﹤0.01% | 827 |
|
|
2015
Q2 | $1.31M | Hold |
7,000
| – | – | 0.01% | 817 |
|
|
2015
Q1 | $1.16M | Hold |
7,000
| – | – | ﹤0.01% | 839 |
|
|
2014
Q4 | $1.63M | Hold |
7,000
| – | – | 0.01% | 813 |
|
|
2014
Q3 | $1.27M | Hold |
7,000
| – | – | 0.01% | 802 |
|
|
2014
Q2 | $1.35M | Buy |
+7,000
| New | +$1.24M | 0.01% | 788 |
|
Other funds holding NKTR
EA
EMFAT
BCM
ACL
ACM
MAP
FMI
State of New Jersey Common Pension Fund D's NKTR Position: Q2 2026 in Review
State of New Jersey Common Pension Fund D increased its Nektar Therapeutics (NKTR) stake by 20% in Q2 2026, buying an estimated $120K and bringing the position to 9,933 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.
State of New Jersey Common Pension Fund D first reported a position in NKTR in Q2 2014 and has held it in 36 quarters since. The position peaked at $19.2M in Q2 2019. 54 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.
- State of New Jersey Common Pension Fund D held 9,933 shares of Nektar Therapeutics worth $693K as of Q2 2026.
- State of New Jersey Common Pension Fund D bought 1,645 Nektar Therapeutics shares in Q2 2026, an estimated $120K.
- Nektar Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1597 holding.
- State of New Jersey Common Pension Fund D first reported a position in Nektar Therapeutics in Q2 2014 and has held it in 36 quarters since.
- State of New Jersey Common Pension Fund D's Nektar Therapeutics position peaked at $19.2M in Q2 2019.
- 54 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.
Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.